An interventional study of Functional Electrical Stimulation Therapy coupled to a P-300 based Brain-Computer Interface and Conventional Physical Therapy in Stroke, Upper Extremity Paresis and Neuronal Plasticity, sponsored by Instituto Nacional de Rehabilitacion. Recruiting at 1 site in Mexico. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-27.
Sponsored by Instituto Nacional de Rehabilitacion · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Stroke with a site in Mexico — 11 open to participants now, 14 under way, 3 of them phase 3. Stroke · Mexico.
Among the 52 studies in Stroke with a site in Mexico, this one is the 36th largest by planned enrollment of the 39 interventional ones that give a count, is one of 3 that started in 2024, is one of 7 with no phase, reaches primary completion later than 5 of the 13 other live ones, and was the 43rd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →11 of the 52 studies in Stroke with a site in Mexico are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Mexico, Argentina, Australia and 35 more countries
Ages 50+
Hospital General de Mexicali · Sites in Mexico
Ages 18+
Hospital Universitario Dr. Jose E. Gonzalez · Sites in Mexico
Ages 18–80
Ahmed A. Rahim · Sites in Mexico
Ages 18–79
Coordinación de Investigación en Salud, Mexico · Sites in Mexico
Ages 35–70
A study can be open while its sites in Mexico have not opened yet or have stopped. Only those recruiting at a site in Mexico →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 4 · Phase 3 25 · Phase 4 2
First in 2003; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 26 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 5,081 across the 39 interventional studies, 350 across the 13 observational. Of the 35 that completed or were terminated, 17 (49%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 52 have an industry lead sponsor. The 10 most frequent:
Instituto Nacional de Rehabilitacion is the lead sponsor of 19 studies on the registry; 7 are open to participants now.
Instituto Nacional de Rehabilitacion has 2 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
1 of the studies in Stroke with a site in Mexico that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06811142Instituto Mexicano del Seguro SocialEarly Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence | 2027-02-01 |
Add it to your calendar (.ics) → With an account.
Among the 52 studies in Stroke with a site in Mexico, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this research is to evaluate the efficacy of an experimental therapy for motor recovery of the arm after a stroke, which includes the application of a functional electrical stimulation therapy coupled to P-300 based Brain-Computer Interface system (BCI-FES). For this purpose, the investigators will compare two groups, the first one will receive only conventional physical therapy, while the second one will receive physical conventional therapy together with BCI-FES therapy.
The control and experimental group will receive 20 sessions of conventional physical therapy at a rate of five sessions per week for 4 weeks, and the experimental group will receive 20 sessions of rehabilitation with the BCI-FES system at a rate of five sessions per week for 4 weeks. Broadly speaking, the BCI is in charge of determining the movement selected by the individual and assist the hand movement while performing functional tasks. The movements included in the sessions will be hand opening, grasping, pinching, pronation and supination, which are combined to facilitate the execution of functional movements that are performed together with the manipulation of daily used utensils. The visual, sensory and motor feedback provided by the BCI-FES system that enables the individual to replicate the afferent-efferent motor circuit, contributes to the activation and recruitment of neural pathways, which is associated with motor recovery.
It should be noted that this BCI-FES system has already been tested previously in a study with healthy individuals, and in a non-randomized pilot study that used this therapy for upper limb motor function recovery in chronic post-stroke patients. It showed positive results, and the therapy was safe and tolerated by all the patients. Besides no adverse event related to the intervention occurred.
To evaluate the results, a series of tests will be applied to assess the motor recovery and level of independence, including the FMA-UE: Fugl-Meyer Assessment Scale of Upper Extremity, ARAT: Action Research Arm Test, MAS: Modified Ashworth Scale, FIM: Functional Independence Measure and MAL: Motor Activity Log. Moreover, to assess neuroplasticity, two neuroimaging techniques including magnetic resonance imaging and electroencephalography will be used.
About one third of patients who suffer a stroke remain with a severe and permanent disability, secondary to motor sequelae and reduced mobility. Physical and occupational therapy represents the main rehabilitation alternative in patients with paretic upper limb, however, despite this, after six months of the event about two thirds of the patients will still be unable to use the affected limb in their daily life activities.
This has led to the development of new therapeutic alternatives able to enhance the effects of conventional physical therapy. The use of brain-computer interfaces represents a paradigm in neurorehabilitation of the upper limb since it can interpret the users intentions and allow them to interact with the environment by facilitating motion execution. Some effector devices that facilitate this movement execution have been tested, with functional electrical stimulation being one of the most used.
Therefore, the objective of this research is to evaluate the efficacy of an experimental therapy for motor recovery of the arm after a stroke, which includes the application of a functional electrical stimulation therapy coupled to P-300 based Brain-Computer Interface system (BCI-FES). For this purpose, the investigators will compare two groups, the first one will receive only conventional physical and occupational therapy, while the second one will receive conventional therapy together with BCI-FES therapy.
Twenty-six subjects with moderate to severe paretic upper limb and history of chronic stroke will be invited to participate in the study. These will be recruited through the patient database of the neurological rehabilitation department of the National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra (INRLGII), in addition to patients recommended by the stroke rehabilitation department.
They will be randomized into two groups: the experimental group will receive P300-BCI-FES therapy together with conventional physical therapy and the control group will receive only conventional physical therapy. They will be randomly assigned to either group according to a big stick design and covariate-adaptive randomization method, considering the following variables for stratification: type of stroke (ischemic/hemorrhagic) and chronicity, baseline Fugl-Meyer Assessment Scale of Upper Extremity score, and age.
Sociodemographic variables and relevant clinical history will be collected. In addition, a series of clinical measurements will be performed through a battery of tests that will allow to know the degree of functional level of the upper limb and self-perception regarding their ability to use it in daily activities through the following scales: FMA-UE: Fugl-Meyer Assessment Scale of Upper Extremity, ARAT: Action Research Arm Test, MAS: Modified Ashworth Scale, FIM: Functional Independence Measure, MAL: Motor Activity Log. Additionally, the Patient Health Questionnaire-9 (PHQ-9) will be performed to measure and monitor the degree of depression perceived by the patients. These tests will be performed before and at the end of the intervention in both groups.
Twenty rehabilitation sessions will be performed with the P300-BCI-FES system with an approximate duration of 45 minutes, at a rate of five sessions per week for 4 weeks. It was decided to provide intensive therapy, since greater effectiveness and a higher degree of recovery have been seen in stroke patients who receive intensive rehabilitation than those who do not receive intensive rehabilitation. Together, the physician and the group of researchers from the division of medical engineering will conduct the rehabilitation sessions. The medical engineering researchers will be in charge of the technical aspects of the system, both on the FES and BCI side. On the other hand, the physician will be in charge of the patient and therapy aspects, verifying that the movements are performed as naturally as possible, and continuously assessing safety and fatigue during the sessions.
The P300 BCI-FES system, to be used for the intervention, consists mainly of two medical devices and a computer running the programs that control the operation of the medical devices and the BCI. The medical equipment consists of a biomedical signal acquisition system (g.Nautilus, g.tec medical engineering GmbH, Schiedlberg, Austria), and an electrical stimulation system (Rehastim 2, Hasomed GmbH, Magdeburg, Germany). Both devices comply with the international standard for medical devices (IEC/EN 60601).
Broadly speaking, the BCI (signal acquisition system + control software) is responsible for determining the movement selected by the patient, and for sending the corresponding command to the Neuroprosthesis (stimulator + control software), which in turn sends the stimulation sequences to the corresponding electrodes, to assist the patient's movement during the practice of upper limb functional tasks.
Patients will be asked to wear comfortable clothes, washed and dry hair, without having applied any creams or gels. A wireless acquisition system will be used to record EEG signals. EEG signals will be recorded from 13 EEG channels using the extended international system 10-20 (F3, F4, Cz, C3, C4, Pz, P3 P4, PO3, PO4, PO7, PO8, Oz, common reference in the right earlobe, ground in AFz). The programmable electrical stimulator Rehastim 2 will be used for electrical stimulation. The BCI2000 software platform will be used to perform all BCI tasks: EEG signal acquisition, ERP feature extraction, signal processing and classification, and finally prediction of the user-selected target motion. Once the target motion is selected, the BCI sends the corresponding output command to the FES control block, developed in MATLAB 2017b and Simulink, which in turn activates the FES system.
To conduct the rehabilitation sessions with the P300-BCI-FES system proposed above, a modified version of the classic matrix system P300 Donchin Speller Interface will be used, where the letters and characters will be replaced by images of hand movements and gestures including: hand opening, grasping, pinching, pronation and supination. The BCI approach will be based on the oddball paradigm, relying on conscious recognition by the user of the intensification (color change and increase in size) of a specific target containing a hand movement or gesture, within a sequence of other non-target random visual stimuli. This will elicit the P300 component in the event related potential.
A calibration session will be undertaken to obtain a first record of EEG signals that will be used to train a classification algorithm (stepwises method linear discrimination analysis, SWLDA), using the P3Classifier tool of the BCI2000 platform. The classifier coefficients obtained in this calibration session will be used during the BCI-FEST session to predict user-selected targets.
FES calibration will be performed with four pairs of transcutaneous adhesive electrodes, which are divided into two channels, one in charge of activating the flexor muscles of the wrist and fingers and the other in charge of activating the extensor muscles of the wrist and fingers. The anatomical targets of these electrodes will be the median, ulnar and radial nerves, which innervate the flexor-extensor muscles of the wrist and fingers. Channel 1 will activate the wrist flexors flexor carpi radialis and flexor carpi ulnaris; channel 2 will activate the finger flexors palmaris longus, flexor digitorum superficialis, flexor digitorum profundus; channel 3 will activate the wrist extensors extensor carpi radialis longus, extensor carpi radialis brevis, extensor carpi ulnaris; channel 4 will activate the finger extensors extensor digitorum, extensor digiti minimi, extensor indicis, extensor pollicis brevis, extensor pollicis longus.
Moreover, rehabilitation sessions will be divided into three phases. The first phase consist of action observation and target selection; in this phase the subject is asked to maintain their attention on a specific image for 20-30 seconds and count the number of times the image is intensified; they are also asked to think as if it was their own hand executing the observed movement. In phase 2 they are asked to do the same as in the first phase, but here the FES system provided passive feedback of the selected target gesture; they are solicited to observe the movement passively, without making any voluntary movements. In phase 3, they are asked to perform a hand gesture and synchronize their voluntary movements with those induced by the FES, thus allowing them to perform a functional task. During the exercises, various objects are used to recreate daily life tasks including bottles, jars, spoons, forks, toothbrushes, pencils, cotton swabs, etc.
This is repeated four times for each hand gesture and in each session the patient selectes six to eight different gestures. If the BCI-FES system correctly recognizes the P300 component, positive feedback is provided according to the selected hand gesture movement; otherwise, neutral feedback is presented and the patient is instructed to remain focused for the next exercise. The execution of hand gestures and task performance will be evaluated every two sessions, so that patients could gradually progress to more complex and difficult movements and tasks. During the intervention, the possible presence of visual fatigue, decreased concentration, muscle fatigue or pain in the upper extremity, skin irritation or redness under the electrodes, and other complications will be carefully monitored.
The benefits of rehabilitation with BCI-integrated systems can be explained by the real-time reproduction of bottom-up and top-down processes of the neural circuits involved in movement execution, thereby enabling voluntary motor control. Properties found in BCI systems that enable this include neurofeedback-associated training, reinforcement-based operant conditioning, repetitive training, and the application of the Hebbian learning principle that allows the completion of the motor intention-action loop affected by stroke.
Conventional physical will be provided over 20 sessions at a rate of 5 sessions per week for 4 weeks, to both groups. It should be noted that the control group received 1 hour of conventional therapy, while the experimental group received only 15 minutes to ensure equal dosage between the two groups. Conventional physical therapy will be focused on the proprioceptive and sensorimotor components of the affected upper extremity in muscle groups: shoulder and arm, elbow and forearm, wrist, hand and phalanges. Thus, joint mobility, range of motion, weight-bearing, sensory re-education, task-specific training and functional exercises led by an experienced professional physical therapist will be administered to both groups.
Additionally, two neuroimaging techniques will be performed including EEG and structural MRI and DTI to assess neuroplasticity after the intervention. The Imaging Division of the National Institute of Rehabilitation has a 3-T MRI scanner and the Neurophysiology Department is in charge of performing electroencephalography studies. These tools will allow us to study the morphological aspects of brain as well as the structural connectivity and functional connectivity, before and after therapy sessions, thus facilitating us to evaluate the neuroplastic changes elicited by the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The experimental group will receive both Functional Electrical Stimulation therapy coupled to the P300-based Brain-Computer Interface system and conventional physical therapy.
Device: Functional Electrical Stimulation Therapy coupled to a P-300 based Brain-Computer Interface · Other: Conventional Physical Therapy
The control group will receive double conventional physical therapy to equalize the time dosages received by the experimental group.
Other: Conventional Physical Therapy
The intervention involves a BCI control strategy based on a modified version of the classic P300 Donchin Speller Interface, where the matrix of letters and symbols is replaced by a set of pictures including five hand gestures and wrist orientations: hand opening, grasping, pinching, pronation, and supination. This BCI approach is based on the oddball paradigm, relying on conscious recognition by the user of the intensification of a particular target movement picture, within a sequence of other, non-target, random visual stimuli. This process should evoke the P300 component in the event related potential. The aim of the training sessions is to link an action observation/target selection task, mediated by the P300-based BCI, with the practice of a FES-assisted functional task involving the target movement picture selected. Users will be instructed to synchronize their voluntary movements with the ones induced by FES, to achieve the functional target goal.
Conventional physical and occupational therapy will include sessions of joint mobility, muscle strength, task-specific training, sensitivity reeducation and coordination exercises directed by an experienced professional therapist.
Upper limb motor recovery
Fugl-Meyer Assessment Scale of Upper Extremity (FMA-UE), Minimum Value: 0 - Maximum Value: 66, Higher Score = Better Outcome.
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Upper limb function
Action Research Arm Test (ARAT), Minimum Value: 0 - Maximum Value: 57, Higher Score = Better Outcome.
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Upper limb spasticity
Modified Ashworth Scale (MAS), Minimum Value: 0 - Maximum Value: 4, Higher Score = Worse Outcome.
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Upper limb functional independence
Functional Independence Measure (FIM), Minimum Value: 18 - Maximum Value: 126, Higher Score = Better Outcome.
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Upper limb functional independence.
Motor Activity Log (MAL-30), Minimum Value: 0 - Maximum Value: 150, Higher Score = Better Outcome.
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Structural Anatomy, Structural Connectivity and Functional Connectivity
Measured through structural MRI, Diffusion Tensor Imaging (DTI) and Electroencephalography
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Severity of depression
The Patient Health Questionnaire (PHQ-9), Minimum Value: 0 - Maximum Value: 27, Higher Score = Worse Outcome.
Time frame: It will be assessed at baseline before beginning the intervention, and after the end of intervention (4 weeks later).
Plan to share: No
Started Aug 2024 (actual). Primary completion is estimated for Jul 2025, 11 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 11 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Nacional de Rehabilitacion